ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 50 filers reported holding ALBIREO PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $444,000 | -60.9% | 22,380 | -30.6% | 0.00% | 0.0% |
| Q2 2021 | $1,135,000 | -6.0% | 32,270 | -5.8% | 0.00% | 0.0% |
| Q1 2021 | $1,208,000 | -10.2% | 34,270 | -4.4% | 0.00% | 0.0% |
| Q4 2020 | $1,345,000 | -4.4% | 35,860 | -14.9% | 0.00% | -50.0% |
| Q3 2020 | $1,407,000 | +14.0% | 42,150 | -9.5% | 0.00% | 0.0% |
| Q2 2020 | $1,234,000 | -74.6% | 46,570 | -84.3% | 0.00% | -50.0% |
| Q1 2020 | $4,856,000 | +25.7% | 296,676 | +95.2% | 0.00% | -20.0% |
| Q4 2019 | $3,863,000 | +9.2% | 151,950 | -14.0% | 0.01% | 0.0% |
| Q3 2019 | $3,536,000 | +84.0% | 176,778 | +196.6% | 0.01% | +25.0% |
| Q2 2019 | $1,922,000 | -5.9% | 59,600 | -6.0% | 0.00% | -20.0% |
| Q1 2019 | $2,042,000 | +15.3% | 63,410 | -12.2% | 0.01% | +25.0% |
| Q4 2018 | $1,771,000 | +4.4% | 72,190 | +40.3% | 0.00% | +33.3% |
| Q3 2018 | $1,696,000 | -12.0% | 51,450 | -5.2% | 0.00% | -25.0% |
| Q2 2018 | $1,927,000 | +3.1% | 54,270 | -5.4% | 0.00% | 0.0% |
| Q1 2018 | $1,869,000 | – | 57,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
| Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
| Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
| SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
| BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
| Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
| PA Capital LLC | 14,692 | $360,000 | 0.38% |
| Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
| Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |